XML 45 R34.htm IDEA: XBRL DOCUMENT v3.25.1
STOCK-BASED COMPENSATION (Tables)
3 Months Ended
Mar. 31, 2025
Share-Based Payment Arrangement [Abstract]  
SCHEDULE OF STOCK OPTIONS OUTSTANDING

Activity in the various Plans during the three months ended March 31, 2025 and 2024 is reflected in the following table:

 

Options  Number of
Shares
  

Weighted

Average
Exercise Price

 
Outstanding at January 1, 2025   2,625   $902.80 
Granted        
Exercised        
Forfeited        
Outstanding at March 31, 2025   2,625   $902.80 
Exercisable at March 31, 2025   2,625   $902.80 

 

Options  Number of
Shares
  

Weighted

Average
Exercise Price

 
Outstanding at January 1, 2024   2,280   $911.00 
Granted        
Exercised        
Forfeited        
Outstanding at March 31, 2024   2,280   $911.00 
Exercisable at March 31, 2024   2,280   $911.00 
SCHEDULE OF SHARES AUTHORIZED UNDER STOCK OPTION PLANS BY EXERCISE PRICE RANGE

The following table summarizes the range of exercise prices and weighted average remaining contractual life for outstanding and exercisable options under the Company’s option plans as of March 31, 2025:

 

    Outstanding options  Exercisable options
Exercise price
range
   Number of
options
   Weighted average
remaining
contractual life
  Number of
options
   Weighted average
remaining
contractual life
                
$0.01 to $999.99    1,850   5.4 years   1,850   5.4 years
$1,000.00 to $1,399.99    700   3.5 years   700   3.5 years
$1,400.00 to $1,799.99    75   1.1 years   75   1.1 years
                   
 Total    2,625   4.7 years   2,625   4.7 years
SCHEDULE OF RESTRICTED STOCK ACTIVITY

A summary of all restricted stock activity under the equity compensation plans for the three months ended March 31, 2025 and 2024 is as follows:

 

   Number of
Restricted
shares
  

Weighted

average
grant date
fair value

 
Nonvested balance, January 1, 2025   2,537   $109.60 
Granted        
Vested   (1,687)   (70.60)
Forfeited        
Nonvested balance, March 31, 2025   850   $187.20 

 

   Number of
Restricted
shares
  

Weighted

average
grant date
fair value

 
Nonvested balance, January 1, 2024   2,694   $225.40 
Granted   4,010    42.40 
Vested   (1,538)   (201.20)
Forfeited   (56)   (444.00)
Nonvested balance, March 31, 2024   5,110   $86.80 
SCHEDULE OF NON-VESTED BALANCE OF RESTRICTED STOCK

The nonvested balance of restricted stock vests as follows:

 

Years ended  Number of
shares
 
     
2025 (April 1, 2025 to December 31, 2025)   75 
2026   325 
2027   250 
2028   200 
2029